Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
5 Relatively Safe And Cheap Dividend Stocks To Invest In - January 2023
02:30pm, Saturday, 07'th Jan 2023 Seeking Alpha
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms.
This Unstoppable Stock Is Approaching a Once-in-a-Decade Buying Opportunity
12:20pm, Saturday, 07'th Jan 2023 The Motley Fool
Johnson & Johnson's upcoming spinoff could lead to better returns, and it'll happen before 2024.
Tesla: Woke Mob Fury - 20 Top Growth Stocks Ranked
12:07pm, Saturday, 07'th Jan 2023 Seeking Alpha
Tesla shares are down 70%, despite the fact that revenues and profits keep growing rapidly. Read more to see why TSLA is a Buy for long-term growth investors.
3 No-Brainer Dividend Stocks to Buy in 2023
11:10am, Saturday, 07'th Jan 2023 The Motley Fool
These stocks have what it takes to win over the long run.
The 3 Best Warren Buffett Dividend Stocks to Buy Now
10:52am, Saturday, 07'th Jan 2023 The Motley Fool
All three were winners for Buffett in 2022.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - January 2023
09:30am, Saturday, 07'th Jan 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. It's alwa
This Unstoppable Stock Is Approaching a Once-in-a-Decade Buying Opportunity
07:20am, Saturday, 07'th Jan 2023
Johnson & Johnson's upcoming spinoff could lead to better returns, and it'll happen before 2024.
3 No-Brainer Dividend Stocks to Buy in 2023
06:10am, Saturday, 07'th Jan 2023
These stocks have what it takes to win over the long run.
The 3 Best Warren Buffett Dividend Stocks to Buy Now
05:52am, Saturday, 07'th Jan 2023
All three were winners for Buffett in 2022.
Kenvue Begins IPO Process As It Seeks To Separate From Johnson & Johnson
05:19am, Saturday, 07'th Jan 2023 Seeking Alpha
Kenvue has filed to go public as part of its separation process from parent firm Johnson & Johnson. Click to read my initial impressions of KVUE IPO.
Dividend Income Summary: Lanny's December 2022 Summary
04:52am, Saturday, 07'th Jan 2023
A decade of investing is snowballing on its own, but we keep investing as much as we can. In December, we (my wife and I) received a dividend income total of $8,110.03.
Kenvue Begins IPO Process As It Seeks To Separate From Johnson & Johnson
12:19am, Saturday, 07'th Jan 2023
Kenvue has filed to go public as part of its separation process from parent firm Johnson & Johnson. The company sells consumer healthcare and wellness products worldwide.
FATE To End Janssen Deal and Prioritize Pipeline Development
06:55pm, Friday, 06'th Jan 2023 Zacks Investment Research
FATE decides not to continue its collaboration and option agreement with Janssen. The company also conducts a strategic review.
Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging
03:54pm, Friday, 06'th Jan 2023 The Motley Fool
The Nasdaq Composite once again is underperforming the rest of the market.
CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC
03:48pm, Friday, 06'th Jan 2023
Layoffs have been making headlines so far in 2023, even though we're just a few days into the new year. That's true even for gene-editing stocks.
